Primecap Management Co. CA Has $365.40 Million Holdings in Agilent Technologies Inc (NYSE:A)

Share on StockTwits

Primecap Management Co. CA cut its holdings in Agilent Technologies Inc (NYSE:A) by 0.2% in the 1st quarter, Holdings Channel reports. The fund owned 4,545,930 shares of the medical research company’s stock after selling 7,450 shares during the period. Primecap Management Co. CA’s holdings in Agilent Technologies were worth $365,402,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also modified their holdings of the company. Captrust Financial Advisors grew its stake in shares of Agilent Technologies by 2,121.1% during the 4th quarter. Captrust Financial Advisors now owns 422 shares of the medical research company’s stock valued at $29,000 after buying an additional 403 shares during the period. Lake Point Wealth Management purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at $30,000. JOYN Advisors Inc. grew its stake in shares of Agilent Technologies by 186.6% during the 4th quarter. JOYN Advisors Inc. now owns 470 shares of the medical research company’s stock valued at $32,000 after buying an additional 306 shares during the period. Destination Wealth Management grew its stake in shares of Agilent Technologies by 100.0% during the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after buying an additional 200 shares during the period. Finally, Truehand Inc purchased a new stake in shares of Agilent Technologies during the 4th quarter valued at $33,000.

Several analysts have recently issued reports on A shares. Zacks Investment Research cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, May 16th. Barclays lowered their price objective on shares of Agilent Technologies from $88.00 to $86.00 and set an “overweight” rating for the company in a research note on Wednesday, May 15th. Wolfe Research started coverage on shares of Agilent Technologies in a research note on Thursday, May 30th. They set a “peer perform” rating for the company. Bank of America reissued a “buy” rating and set a $87.00 price objective (up from $78.00) on shares of Agilent Technologies in a research note on Thursday, February 21st. Finally, UBS Group started coverage on shares of Agilent Technologies in a research note on Friday, March 15th. They set a “buy” rating and a $92.00 price objective for the company. Three analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus target price of $86.31.

Agilent Technologies stock traded down $0.11 during trading on Friday, reaching $70.19. 221,201 shares of the company’s stock were exchanged, compared to its average volume of 3,059,181. The company has a current ratio of 3.41, a quick ratio of 2.82 and a debt-to-equity ratio of 0.35. Agilent Technologies Inc has a 52-week low of $60.42 and a 52-week high of $82.27. The stock has a market cap of $22.12 billion, a price-to-earnings ratio of 25.16, a price-to-earnings-growth ratio of 1.96 and a beta of 1.40.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, May 14th. The medical research company reported $0.71 earnings per share for the quarter, missing analysts’ consensus estimates of $0.72 by ($0.01). Agilent Technologies had a return on equity of 19.71% and a net margin of 22.25%. The business had revenue of $1.24 billion for the quarter, compared to analysts’ expectations of $1.27 billion. During the same period last year, the company posted $0.65 earnings per share. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. Analysts forecast that Agilent Technologies Inc will post 3.05 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 24th. Investors of record on Tuesday, July 2nd will be given a dividend of $0.164 per share. The ex-dividend date is Monday, July 1st. This represents a $0.66 dividend on an annualized basis and a yield of 0.93%. Agilent Technologies’s dividend payout ratio (DPR) is 23.66%.

In other Agilent Technologies news, SVP Michael Tang sold 6,728 shares of the company’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $80.50, for a total value of $541,604.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Paul N. Clark sold 2,823 shares of the company’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $80.31, for a total transaction of $226,715.13. Following the completion of the transaction, the director now directly owns 88,857 shares of the company’s stock, valued at $7,136,105.67. The disclosure for this sale can be found here.

COPYRIGHT VIOLATION NOTICE: This news story was originally published by Ticker Report and is owned by of Ticker Report. If you are accessing this news story on another domain, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The correct version of this news story can be accessed at https://www.tickerreport.com/banking-finance/4371473/primecap-management-co-ca-has-365-40-million-holdings-in-agilent-technologies-inc-nysea.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.

Further Reading: What is range trading?

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

MarketAxess Holdings Inc.  Shares Sold by Primecap Management Co. CA
MarketAxess Holdings Inc. Shares Sold by Primecap Management Co. CA
Vanguard Mid-Cap ETF  Shares Sold by Koshinski Asset Management Inc.
Vanguard Mid-Cap ETF Shares Sold by Koshinski Asset Management Inc.
Primecap Management Co. CA Has $365.40 Million Holdings in Agilent Technologies Inc
Primecap Management Co. CA Has $365.40 Million Holdings in Agilent Technologies Inc
Koshinski Asset Management Inc. Buys 2,090 Shares of Vanguard Total Stock Market ETF
Koshinski Asset Management Inc. Buys 2,090 Shares of Vanguard Total Stock Market ETF
GYL Financial Synergies LLC Invests $910,000 in Allegiant Travel
GYL Financial Synergies LLC Invests $910,000 in Allegiant Travel
Riverhead Capital Management LLC Purchases 51,693 Shares of Morgan Stanley
Riverhead Capital Management LLC Purchases 51,693 Shares of Morgan Stanley


© 2006-2019 Ticker Report